![]() |
市场调查报告书
商品编码
1701831
PET-CT 扫描仪设备市场报告(按类型、切片数量、同位素和探测器类型、服务提供者、应用和地区)2025 年至 2033 年PET-CT Scanner Device Market Report by Type, Slice Count, Isotope and Detector Type, Service Provider, Application, and Region 2025-2033 |
2024 年全球 PET-CT 扫描仪设备市场规模达 23 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 32 亿美元,2025-2033 年期间的成长率 (CAGR) 为 3.44%。由于生活方式的改变和环境因素导致癌症盛行率上升,技术创新的不断增加导致成像品质、效率和患者安全性的提高,以及老年人口的不断增长,市场正在经历稳定的增长。
市场成长与规模:由于医疗保健基础设施的改善以及对先进影像技术的投资增加,市场正在稳步成长。
技术进步:人工智慧 (AI) 演算法和多模式成像功能的整合正在增强诊断能力并简化工作流程。
产业应用:PET-CT 扫描仪设备可用于心血管和神经系统疾病。
地理趋势:亚太地区引领市场,受新医院、诊断中心和专科诊所数量的不断增加所推动。然而,随着人们对早期诊断益处的认识不断提高,北美正在成为一个快速成长的市场。
竞争格局:主要参与者正在投资研发 (R&D) 活动,以开发具有改进的影像能力、增强的诊断准确性和病患舒适度的创新 PET-CT 扫描仪技术。
挑战与机会:市场在面临初始成本高等挑战的同时,也因 PET-CT 影像应用范围的扩大而面临机会。
未来展望:随着个人医疗保健需求的不断变化,PET-CT 扫描仪设备市场的未来前景光明。此外,紧凑型和便携式 PET-CT 扫描仪的不断发展将实现 PoC 成像,预计这将促进市场成长。
癌症发生率上升
全球癌症发生率的不断上升推动了 PET-CT 扫描仪设备市场的成长。 PET-CT 扫描仪在癌症诊断、分期和治疗监测中发挥关键作用。透过 PET-CT 影像进行早期检测可提高治疗效果和患者预后,从而促进其广泛应用。此外,医疗保健提供者越来越依赖 PET-CT 扫描来准确表征疾病并制定个人化治疗计划。这些扫描利用癌细胞选择性吸收的放射性药物,从而可以观察到肿瘤内的代谢活动。同时,CT 扫描提供详细的解剖影像,有助于精确定位 PET 检测到的异常代谢活动。 PET-CT 扫描所获得的综合资讯可帮助肿瘤科医师就治疗策略(包括手术、放射线治疗、化学疗法和标靶疗法)做出明智的决定。此外,PET-CT 扫描可以及时开始治疗并可能改善患者的治疗效果。人们越来越需要改善获得先进诊断工具的机会来对抗癌症。
技术进步
PET-CT 扫描仪的创新有助于提高影像品质、效率和病患安全性。现代 PET-CT 扫描仪具有更高的空间分辨率,可更清晰地显示小病变并提高肿瘤检测和表征的准确性。这项进步使得更早的诊断和更精确的治疗计划成为可能。此外,先进的 PET-CT 扫描仪可缩短扫描时间,有助于减少患者的不适并提高医疗保健环境中的工作流程效率。快速影像撷取使临床医生能够在一定时间内进行更多扫描,从而增加患者吞吐量并提高资源利用率。此外,PET-CT 技术的进步正在推动辐射剂量更低同时保持诊断影像品质的扫描仪的开发。这些扫描仪透过最大限度地减少患者受到的辐射,提高了安全性并降低了与重复成像研究相关的长期不良影响的风险。除此之外,采用呼吸门控和运动追踪等先进运动校正技术的 PET-CT 扫描器可确保影像更清晰、无伪影。
老年人口不断增加
由于全球老龄人口不断增加,对 PET-CT 扫描仪设备的需求不断增长,对市场产生了积极影响。老年人更容易患癌症、阿兹海默症、心血管疾病和其他慢性疾病,因此需要先进的设备来准确检测和监测疾病。 PET-CT 扫描仪可全面评估心臟功能、心肌灌注和活力,有助于诊断和治疗老年患者的心血管疾病。此外,老化也会增加神经退化性疾病的风险。 PET-CT 影像为大脑代谢、淀粉样蛋白沉积和神经受体结合提供了宝贵的见解,有助于老年人的早期诊断和疾病监测。除此之外,老年患者通常患有多种合併症,需要全面的诊断评估。 PET-CT 扫描仪具有多模式影像功能,可在一次检查中同时评估多个器官系统。这种综合方法有助于简化诊断工作流程并增强管理老年人复杂健康状况的临床决策能力。
The global PET-CT scanner device market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.
Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.
Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.
Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.
Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.
Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.
Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.
Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.
Rising prevalence of cancer cases
The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.
Technological advancements
Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.
Increasing geriatric population
The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.
Stationary scanners account for the majority of the market share
Medium slice scanner (64 slices) holds the largest market share
Flurodeoxyglucose (FDG) represents the leading market segment
Hospitals exhibit a clear dominance in the market
Oncology dominates the market share
Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: